ARTICLE | Company News
Talecris sales and marketing update
November 8, 2010 8:00 AM UTC
Talecris launched Prolastin-C in Canada to treat panacinar emphysema in patients with alpha1-antitrypsin ( AAT) deficiency. The company said Prolastin-C, which is a more purified and concentrated for...